BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1457860)

  • 1. Implantation of a cardioverter-defibrillator after coronary artery bypass surgery.
    Cernaianu AC; Cilley JH; Libby JA; Volosin R; DelRossi AJ
    ASAIO J; 1992; 38(3):M257-60. PubMed ID: 1457860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic implantable defibrillator patches in patients at high risk for malignant ventricular dysrhythmias.
    Tedder M; Anstadt MP; Wharton JM; Revishvili AS; Hegde SS; Lowe JE
    ASAIO J; 1992; 38(3):M261-5. PubMed ID: 1457861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death.
    Daoud EG; Niebauer M; Kou WH; Man KC; Horwood L; Morady F; Strickberger SA
    Am Heart J; 1995 Aug; 130(2):277-80. PubMed ID: 7631607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined internal cardioverter-defibrillator implantation and myocardial revascularization for ischemic ventricular arrhythmias: optimal cost-effective strategy.
    Lee JH; Folsom DL; Biblo LA; Carlson MD; Johnson NJ; Waldo AL; Geha AS
    Cardiovasc Surg; 1995 Aug; 3(4):393-7. PubMed ID: 7582993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable defibrillators for secondary prevention of sudden cardiac death in cardiac surgery patients with perioperative ventricular arrhythmias.
    Nageh MF; Kim JJ; Chen LH; Yao JF
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25146702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Di Marco A; Anguera I; Nombela-Franco L; Oloriz T; Teruel L; Rodriguez Mañero M; Toquero J; León V; Dallaglio P; Perez Guerrero A; Salazar CH; Escaned J; Asso Abadía A; Gomez Hospital JA; Cequier A
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E1-E11. PubMed ID: 32460428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of revascularization on mortality and risk of ventricular arrhythmia in patients with ischemic cardiomyopathy.
    Alkharaza A; Al-Harbi M; El-Sokkari I; Doucette S; MacIntyre C; Gray C; Abdelwahab A; Sapp JL; Gardner M; Parkash R
    BMC Cardiovasc Disord; 2020 Oct; 20(1):455. PubMed ID: 33087069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of literature.
    Autschbach R; Falk V; Gonska BD; Dalichau H
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):552-8. PubMed ID: 7513886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ; Kron J; Dunnigan A; Dick M
    Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.
    Cook JR; Rizo-Patron C; Curtis AB; Gillis AM; Bigger JT; Kutalek SP; Coromilas J; Hofer BI; Powell J; Hallstrom AP;
    Am Heart J; 2002 May; 143(5):821-6. PubMed ID: 12040343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.
    Sueda S; Kohno H
    Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death.
    Elhendy A; Chapman S; Porter TR; Windle J
    J Am Coll Cardiol; 2005 Nov; 46(9):1721-6. PubMed ID: 16256875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass grafting and defibrillator implantation in patients with ventricular tachyarrhythmias and ischemic heart disease.
    Geelen P; Primo J; Wellens F; Brugada P
    Pacing Clin Electrophysiol; 1999 Aug; 22(8):1132-9. PubMed ID: 10461287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.
    Bigger JT; Whang W; Rottman JN; Kleiger RE; Gottlieb CD; Namerow PB; Steinman RC; Estes NA
    Circulation; 1999 Mar; 99(11):1416-21. PubMed ID: 10086963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: does bypass surgery suffice?
    Natale A; Sra J; Axtell K; Maglio C; Dhala A; Blanck Z; Deshpande S; Jazayeri M; Akhtar M
    J Cardiovasc Electrophysiol; 1994 Dec; 5(12):988-94. PubMed ID: 7697208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.